Market Definition
A type of packaging that is specially designed to store & protect the drugs or medication in the pharmaceutical sector is termed pharmaceutical blister packaging. It consists of a covering material, composed of aluminum foil, paperboard, or plastic film, along with a plastic blister or hollow on the other side that contains a single dose of medication or drug.
Market Insights & Projections: North America Pharmaceutical Blister Packaging Market (2023-28):
The North America Pharmaceutical Blister Packaging Market is valued at XX billion in 2022 & is estimated to grow at a CAGR of around XX% during the forecast period, i.e., 2023-28. With the rising demand for pharmaceutical blister packaging across a range of end-users, such as the pharmaceutical sector, the market is envisioned to register a modest growth percentage in the years ahead. When it comes to packaging products that need to be protected from external factors, blister packs are growing in popularity.
Besides being applicable to other medical devices, they can be utilized for injectable vials, inhalers, capsules, and tablets. They are also well-liked for preserving consumables like medicines, etc. As this packaging offers great safety solutions to protect any kind of pharmaceutical product or medication, its demand is foreseen to heighten. The US Food and Drug Administration (FDA) in the United States & Health Canada in Canada are two organizations overseeing North America's pharmaceutical sector.
| Report Coverage | Details |
|---|---|
| Study Period | Historical Data: 2018-21 |
| Base Year: 2022 | |
| Forecast Period: 2023-28 | |
| Country Covered | The USA, Canada, Mexico |
| Key Companies Profiled | Amcor PLC, Westrock Company, Constantia Flexibles , Sonoco Products Company, Honeywell International Inc, Klockner Pentaplast , Gerresheimer AG, Rohrer Corporation, Aphena Pharma Solutions, Winpack Ltd., Others |
| Unit Denominations | USD Million/Billion |
To assure product safety, efficiency, and quality, these organizations have established several guidelines & standards for pharmaceutical packaging, including blister packing. The stringent regulations & the rising need for this packaging from the manufacturers & consumers, as well as the progression in over-the-counter drugs, are also proliferating the usage of pharmaceutical blister packaging in the North America Pharmaceutical Blister Packaging Market.
The region has a well-established pharmaceutical industry & is home to the leading & innovative pharma & biopharma industries and drug developers, owing to its high investments & rigorous R&D. Since, the past few decades the industry has shown tremendous growth, owing to which much larger pool of consumers have access to all types of medication & to maintain the same easy availability of the medicines numerous pharmaceutical manufacturers are working at a great pace & produces a huge amount of medications.
Moreover, owing to the outbreak of COVID-19, several medical industries enhanced their R&D as well as extended their manufacturing sector to satisfy the soaring need for drugs & vaccines across the region. Thus, in line with the upgrading production of medication the pharmaceutical blister packaging has been registering extraordinary demand, which is eventually leading to enhanced market growth.
Additionally, the concern about the manufacturing of prescription drugs at the retail level by pharmaceutical technologists or chemists regarding sensitive medications that could have a harmful impact when being transported from container to container in the open environment of the supermarket & drug store is one of the aspects that is encouraging the adoption of pharmaceutical blister packaging. As this packaging protects the products against humidity, contamination for a prolonged period of time, and destruction, thereby increasing their shelf life. Along with this, the rise in the adoption for developing sustainable blister packaging among the regional manufactures is revolutionizing the North America Pharmaceutical Blister Packaging Market & would be a potential trend in the industry.
On top of that, pharmaceutical firms that serve the drug sector are spending capital to expand their manufacturing facilities in North America. For instance, Lubrizol Life Science Health unveiled Apisolex, a brand-new solubility-improving excipient for parenteral medicinal formulations, in March 2022. Hence, the upscaling expenditure in the production of drugs by the leading pharmaceutical players is presumed to increase the requirement for blister packaging in the following years.
North America Pharmaceutical Blister Packaging Market Driver:
Rising Spending Capitals by Pharmaceutical Sector to Expand Drugs Manufacturing to Influence the Market Growth – With the surging percentage of individuals suffering from several types of diseases, North America is witnessing high demand for medication & drugs. Also, in consideration of the recent market situation the pharma sector is investing heavily in R&D activities to enrich & modernize the current production lines. The sector is spending capital on the development of new products & to suffice the need for existing drugs. Numerous leading players have several pharmaceutical drugs in their R&D pipeline. For instance:
Hence, owing to the rising R&D activities & investment by the companies to launch or produce new drugs or medication is creating a massive opportunity for the North America Pharmaceutical Blister Packaging Market. Further, the region is following an advanced & newer manufacturing process, which is more flexible & could expedite the production process, thus strengthening domestic drug manufacturing to sustain the medical requirement of the patients. Therefore, with the soaring production of drugs & medication, owing to the upscaling population suffering from diseases, there would be a boost in demand for packaging. This, in turn, would aid in creating a positive market outlook in the upcoming years.
North America Pharmaceutical Blister Packaging Market Challenge:
Compliance with Strict Regulation to Hinder the Market – North America has no such comprehensive legislation regulating the pharmaceutical sector. However, via FDI, the US does have the authority to regulate the pharmaceutical industry & related sectors to ensure that the industry is meeting safety standards. Therefore, the companies are enforced to follow the regulations to meet the satisfactory need. The strict regulations imposed on blister packaging are creating a barrier to the expansion of the market.
In adherence to the regulations, there should be no small defect, as it would abolish the entire product, which would adversely affect the manufacturer’s profit margin. Moreover, as per the FDI, the packaging must have the name of the manufacturer, lot number, expiration date, bar code, etc. Hence, to fulfill all the regulation extra vigilance & effort is required, leading to surplus cost, time, and resource, further creating a challenge for the manufacturers & eventually hindering the growth of the North America Pharmaceutical Blister Packaging Market.
North America Pharmaceutical Blister Packaging Market Trend:
Innovation & Inclination Towards Sustainable Pharmaceutical Packaging – As we all know, North America is the home to the pharmaceutical sector & the countries of the region, such as the US, and several others, are always focused on improvising & adopt environmentally friendly things. Thus, to overcome environmental issues like carbon emissions, the companies in the region are inclining towards sustainable blister packaging. Several leading companies are investing in blister packaging to satisfy their sustainability targets, improve the reputation of their brands, and win over customers, now that sustainability is a critical factor. For instance:
Consequently, owing to the cutting-edge tactic, blister packaging aims to lessen the environmental impact of conventional packaging materials, simultaneously advancing sustainability efforts. Thus, sustainability packaging has become trending in the North America Pharmaceutical Blister Packaging Market.
North America Pharmaceutical Blister Packaging Market (2023-28): Segmentation Analysis
The North America Pharmaceutical Blister Packaging Market study of MarkNtel Advisors evaluates & highlights the major trends & influencing factors in each segment & includes predictions for the period 2023–2028 at the regional & national levels. Based on the analysis, the market has been further classified as:
Based on Material Type:
Polyethylene Terephthalate (PET) is estimated to be the most prominent material type in the North America Pharmaceutical Blister Packaging market in the forecast years, owing to its strong durability & transparency. This material can withstand high temperatures & act as a barrier to gas & moisture, thus becoming a preferable option for the North American pharmaceutical packaging sector. Further, owing to its high sustainable aspect, its demand is foreseen to enhance in the North America Pharmaceutical Blister Packaging Market during the forthcoming period.
Based on Technology:
Thermoforming is presumed to be the most adopted technology by manufacturers in the market. Faster production & low expense for production in comparison to cold forming are the primary aspects that are inclining the blister packaging manufacturers' interest in the technology. Thermoforming offers safe transit due to its smaller & tightly defined compartments, which lessens the possibility of damage, and visibility owing to transparent blister plastic & privilege of enormous customization. Moreover, with its ability to manufacture high volumes for blister packaging, hygiene, and reliability, it is gaining prevalence among manufacturers, thus becoming one of the contributors in upscaling the revenue growth of the North American market.
North America Pharmaceutical Blister Packaging Market (2023-28): Regional Analysis
Geographically, the North America Pharmaceutical Blister Packaging Market expands across:
The US has captured the dominating share of the market & is anticipated to be the flourishing region in terms of consumption & development of pharmaceutical products. With the strong foothold of the leading players, such as Amcor PLC, and several others, the US is regarded as the significant country aiding in sufficing the medical needs of the domestic as well as the regional population.
The rising elderly population is increasing the rate of diseases in the country, further developing a large scope for pharmaceutical products, which is driving the Pharmaceutical Blister Packaging Market in the country. For instance, the production of pharmaceutical products is anticipated to reach around 365 thousand, by the end of 2024, as per the US Census Bureau. Consequently, due to the growing chronic diseases in the US, there is & would be a surge in the production of newly launched or effective drugs & medications, which is expected to contribute to the growth of the North America Pharmaceutical Blister Packaging Market during 2023-28.
North America Pharmaceutical Blister Packaging Industry Recent Development:
Gain a Competitive Edge with Our North America Pharmaceutical Blister Packaging Market Report
Frequently Asked Questions
A. The North America Pharmaceutical Blister Packaging Market is projected to grow at a CAGR of around 5.8% during 2023-28.
A. The flourishing pharmaceutical sector in the US, driven by the aging population and increasing prevalence of chronic diseases, is the prime aspect projected to drive the North America Pharmaceutical Blister Packaging Market further in the coming years.
A. Amcor PLC, Westrock Company, Constantia Flexibles, Sonoco Products Company, Honeywell International Inc, Klockner Pentaplast , Gerresheimer AG, Rohrer Corporation, Aphena Pharma Solutions, and Winpack Ltd. are the key players operating in the North America Pharmaceutical Blister Packaging Market.
A. Growing concerns over the environmental sustainability and waste management are the major growth restraints for the North America Pharmaceutical Blister Packaging Market.
A. Aclar films would provide remunerative opportunities for the leading players in the North America Pharmaceutical Blister Packaging Market during the forecast period.
A. In North America, the US would continue generating lucrative prospects for the Pharmaceutical Blister Packaging Market in the years ahead.
North America Pharmaceutical Blister Packaging Market Research Report (2023-2028) - Table of Contents
